Artivion Inc
NYSE:AORT

Watchlist Manager
Artivion Inc Logo
Artivion Inc
NYSE:AORT
Watchlist
Price: 28.66 USD 0.84%
Market Cap: 1.2B USD
Have any thoughts about
Artivion Inc?
Write Note

Artivion Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Artivion Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Artivion Inc
NYSE:AORT
Net Issuance of Common Stock
$3.4m
CAGR 3-Years
98%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Net Issuance of Common Stock
-$500m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Boston Scientific Corp
NYSE:BSX
Net Issuance of Common Stock
$219m
CAGR 3-Years
N/A
CAGR 5-Years
13%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Net Issuance of Common Stock
-$253m
CAGR 3-Years
42%
CAGR 5-Years
-100%
CAGR 10-Years
17%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Issuance of Common Stock
$345.3m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Artivion Inc
Glance View

Market Cap
1.2B USD
Industry
Health Care

Artivion, Inc. focuses on developing solutions that address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,300 full-time employees. The firm is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The firm's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. The company offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The firm's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.

AORT Intrinsic Value
24.48 USD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Artivion Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
3.4m USD

Based on the financial report for Dec 31, 2023, Artivion Inc's Net Issuance of Common Stock amounts to 3.4m USD.

What is Artivion Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
14%

Over the last year, the Net Issuance of Common Stock growth was 116%. The average annual Net Issuance of Common Stock growth rates for Artivion Inc have been 98% over the past three years , 14% over the past five years .

Back to Top